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Background: Controversy exists over the use of hydroxyapatite (HA)-coated femoral stems in primary
total hip arthroplasty (THA). We conducted a meta-analysis of randomized controlled trials (RCT) to
compare the clinical and radiologic outcomes of primary THA using HA-coated versus non-HA-coated
femoral stems.
Methods: Databases including MEDLINE, EMBASE and the Cochrane Library were searched to ﬁnd rele-
vant RCTs comparing HA-coated versus non-HA-coated femoral stems in primary THA. Data analyses
were performed using RevMan 5.0 (The Cochrane Collaboration).
Results: Seven studies (792 hips) met the inclusion criteria. The pooled weighted mean difference (WMD)
for the postoperative Harris hip score was 3.04 (95% CI: 4.47 to 10.54, P ¼ 0.43). The cumulative risk
ratios (RR) for the presence of endosteal condensation and radioactive lines were 1.02 (95% CI: 0.93 to
1.12, P ¼ 0.64) and 1.01 (95% CI: 0.90 to 1.14, P ¼ 0.81), respectively.
Conclusions: This meta-analysis demonstrates that the use of HA-coated femoral stems in primary THA
has no clinical or radiological beneﬁts.
Crown Copyright  2013 Published by Elsevier Ltd on behalf of Surgical Associates Ltd. All rights
reserved.1. Introduction
Hydroxyapatite (HA)-coated femoral stems have been used in
primary total hip arthroplasty (THA) for over 20 years.1,2 However,
controversy exists over the use of HA-coated femoral stems in THA.
Some studies have shown that theHAcoating can enhance endosteal
bone ingrowth into theprosthesis, thus improving the stability of the
femoral stem and resulting in better clinical and radiological out-
comes.3,4 However, other studies have shown no advantages asso-
ciated with the use of HA-coated femoral stems in THA.5 Use of HA-
coated femoral stems also has several disadvantages. These include
high cost and thepotential for delamination of theHAcoating,which
can result in third-bodywear of the polyethylene acetabular cup and
subsequent osteolysis and loosening of the prosthesis.6e8
A number of randomized controlled trials (RCTs) have compared
the effectiveness of HA-coated versus non-HA-coated femoral
stems in primary THA. However, the results of these trials have: þ86 771 5356288.
. Li), suweixg@hotmail.com
er.
013 Published by Elsevier Ltd on bbeen inconsistent. Thus, we conducted a meta-analysis of the RCTs
available in the literature in order to reach a conclusion regarding
the effectiveness of HA-coated versus non-HA-coated femoral
stems in primary THA. The null hypothesis was that there were no
differences in the clinical or radiological outcomes after primary
THA using HA-coated or non-HA-coated femoral stems.
2. Methods
2.1. Literature search and inclusion criteria
We searched the Cochrane Central Register of Controlled Trials (in The Cochrane
Library Issue 3, 2011), MEDLINE (from January, 1980 to March, 2011), EMBASE (from
January, 1980 to March, 2011) according to the search strategies recommended by
the Cochrane Collaboration for eligible trials. Literature was included if it met all of
the following criteria: (1) publication in the English language; (2) the patients un-
derwent a primary, uncemented THA; (3) the study was an RCT that compared
identical geometry femoral stems with porous coating either with or without an
applied HA surface coating; (4) studies of bilateral THAs in which an HA-coated
femoral stem was used in one hip and not in the other were included when the
allocation of the two techniques to the operated hips was randomized; (5) the study
outcomes included both clinical and radiological outcomes. Clinical outcomes
included the Harris hip score and the incidence of postoperative thigh pain.
Radiological outcomes included the presence of endosteal condensation (spot
welds), presence of radioactive lines, and incidence of heterotopic ossiﬁcation.
Endosteal condensation is considered a sign of endosteal bone ingrowth on theehalf of Surgical Associates Ltd. All rights reserved.
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Radioactive lines indicate femoral stem instability and are considered a sign of
micromotion and femoral stem loosening.9
2.2. Data extraction and assessment of trial quality
A standard data extraction table was constructed based on a review of the liter-
ature. Two authors extracted data independently and crosschecked mutually. The
extracted information included the ﬁrst author, enrollment period, demographic data,
time of follow-up, number of depletions (withdrawn/dropped out/lost to follow-up),
femoral implant type, and whether or not the study used intention-to-treat analysis.
The methodological quality of the included studies were evaluated independently by
the authorsusing a speciﬁc tool for assessing risk of bias as described byHiggins et al.10
in Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions
(Version5.0.0). This tool comprises a description and judgment foreach entry in a “risk
of bias” table, where each entryaddresses a speciﬁc feature of the study. The judgment
for each entry involves answering a question, with the answer “Yes” indicating a low
risk of bias, “No” indicating a high risk of bias, and “Unclear” indicating either a lack of
information or uncertainty over the potential for bias.
2.3. Data synthesis
Data analysis was performed using RevMan 5.0 statistical software provided by
the Cochrane Collaboration. Two authors checked the data during data entry to
ensure there were no errors. We used the c2 statistic to assess heterogeneity be-
tween trials, where P < 0.1 was considered signiﬁcant. We used a ﬁxed-effect model
for calculations of summary estimates when there was no signiﬁcant statistical
heterogeneity. The random-effect model was adopted when there was statistical
heterogeneity.11 Relative risk (RR) was used as a summary statistic to perform sta-
tistical analyses of dichotomous variables, and the weighted mean difference
(WMD) was used to analyze continuous variables. Both were reported with 95%
conﬁdence intervals (CI), and a P value of 0.05 was used as the level of statistical
signiﬁcance. In addition, a sensitivity analysis was performed by omitting each study
in turn and thus investigating the inﬂuence of a single study on the overall meta-
analysis estimate when necessary.
3. Results
3.1. Literature search and trial characteristics
A total of 512 relevant publications were identiﬁed. After
reading the title, abstract and full text, seven studies12e18 publishedRecords identified through database searching 
(n=512) 
Records after duplicates removed 
(n=434) 
Full-text articles assessed for eligibility 
(n=19)
Studies included in meta-analysis  
(n=7)  
Fig. 1. Flowchart of lbetween 1993 and 2007 met the inclusion criteria. The literature
search procedure is shown in Fig. 1. This diagram has been designed
in accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement.19 A total of 792
hips were included in the seven studies, with 401 in HA groups and
391 in non-HA groups. The duration of follow-up ranged from 1
year to 10.5 years. Additional characteristics of the included studies
are shown in Table 1. Of the seven included studies, four used
adequate random sequence generation,13,16e18 one study had
adequate concealment of allocation,16 and ﬁve used at least
observer blinding.12,15e18 The methods used to generate random
sequences in the included trials are as follows: random number
tables,13,17,18 randomized envelope,16 and not reported.12,14,15 The
methodological quality of the included trials is shown in Table 2.
3.2. Meta-analysis results
The results of the meta-analysis of the outcome measures are
shown in Table 3.
3.2.1. Clinical outcomes
Six studies12,13,15e18 reported the postoperative Harris hip score,
but only the results from four of these studies12,15e17 were pooled.
The summary effects demonstrated that there was no signiﬁcant
difference between the HA and non-HA groups [WMD ¼ 3.04, 95%
CI (4.47, 10.54), random-effects analysis, P ¼ 0.43] (Fig. 2). How-
ever, heterogeneity existed among individual trials (P < 0.00001).
Sensitivity analysis was performed by omitting individual studies
in each round of the analysis. We found that the study by Søballe
et al.15 was the main source of heterogeneity. However, when the
sensitivity analysis was applied after omitting this trial,15 the re-
sults did not change signiﬁcantly [WMD ¼ 0.33, 95% CI (1.91,
2.56), ﬁxed-effects analysis, P ¼ 0.77]. The incidence of post-
operative thigh pain, based on the two studies14,18 that reported it,
was 14 of 129 patients in the HA group and 23 of 120 patients in the
non-HA group. There was no heterogeneity between the individualRecoreds excluded after screening 
of title/abstract(n=415) 
Full-text articles excluded (n=29) 
Reasons for exclusion: 
Non-RCT (n=10) 
Duplicates(n=2) 
iterature search.
Table 1
Characteristics of included studies.
Author and publication
date
Enrollment
period
Number of hips
enrolled HA/
Non-HA
Number of hips
analyzed HA/
Non-HA
Missing outcomes
data HA/Non- HA
Male:
Females
Mean age
(years)
HA/Non-HA
Duration of
follow-up
(years)
Type of implant
Hamadouche
et al., 2001
1988e1990 50(24/26) 45(22/23) 5(2/3) NR 65:64 8.7 ProWle (DePuy)
Kim et al., 2003 NR 100(50/50) 100(50/50) 0(0/0) 36:14 45.3 6.6 IPS (Depuy)
Rasquinha
et al., 2002
1991e1994 199(103/96) 174(92/82) 25(11/14) NR 55/56 4.7 Ranawat-Burstein
(Biomet)
Soballs et al.,
1993
NR 28(15/13) 26(14/12) 2(1/1) NR 57/59 1 Bi-Metric (Biomet)
Tanzer et al.,
2004
NR 359(181/178) 318(159/159) 41(22/19) NR 65/63 3.1 Multilock (Zimmer)
Yee et al., 1999 1989e1992 62(35/27) 54(27/27) 8(8/0) 40/22 48/50 4.3/4.9 Mallory Head (Biomet)
Yoon et al., 2007 1993e1995 84(42/42) 75(37/38) 9(5/4) NR 45/46 10.5 Multilock (Zimmer)
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[95% CI (0.30, 1.02), ﬁxed-effects analysis] with no signiﬁcant dif-
ference between HA and non-HA groups (P ¼ 0.06)(Fig. 3).
3.2.2. Radiographic outcomes
Four studies14e16,18 reported the presence of endosteal
condensation (spot welds) in a total of 184 of 302 patients in the HA
group and 169 of 291 patients in the non-HA group. There was no
heterogeneity between individual studies (P ¼ 0.17). Pooled anal-
ysis demonstrated that there was no signiﬁcant difference between
the HA and the non-HA groups [RR¼ 1.02, 95% CI (0.93, 1.12), ﬁxed-
effects analysis, P ¼ 0.64] (Fig. 4). Five studies14e18 reported the
presence of radioactive lines in a total of 200 of 325 patients in the
HA group and 194 of 318 patients in the non-HA group. The test for
homogeneity showed that results were consistent across trials
(P ¼ 0.97), and there was no statistical difference in the presence of
radioactive lines between the HA and non-HA groups [RR ¼ 1.01,
95% CI (0.90, 1.14), ﬁxed-effects analysis, P ¼ 0.81] (Fig. 5). Three
studies16e18 reported the incidence of heterotopic ossiﬁcation in a
total of 85 of 223 patients in the HA group and 88 of 224 patients in
the non-HA group. There was no heterogeneity between individual
studies (P ¼ 0.20), and the RR of heterotopic ossiﬁcation was 0.97
[95% CI (0.77, 1.21), ﬁxed-effects analysis] with no signiﬁcant dif-
ference between HA and non-HA groups (P ¼ 0.77) (Fig. 6).
4. Discussion
There are a number of RCTs that compare the outcomes of THA
using HA-coated and non-HA-coated femoral stems. The results of
these studies are conﬂicting, with some indicating neither clinicalTable 2
Assessments of risk of bias in included studies.
Included studies Adequate sequence
generation?a
Allocation
concealmentb
Blin
Hamadouche et al., 2001 Unclear Unclear Yes
Kim et al., 2003 Yes Unclear Unc
Rasquinha et al., 2002 Unclear Unclear Unc
Soballs et al., 1993 Unclear Unclear Yes
Tanzer et al., 2004 Yes Yes Yes
Yee et al., 1999 Yesa Unclear Yes
Yoon et al., 2007 Yes Unclear Yes
(Note:quoted from Cochrane handbook for systematic reviews for intervention. Version
a Was the allocation sequence adequately generated? [Short form: Adequate sequenc
b Was allocation adequately concealed? [Short form: Allocation concealment?].
c Was knowledge of the allocated interventions adequately prevented during the stud
d Were incomplete outcome data adequately addressed? [Short form: Incomplete out
e Are reports of the study free of suggestion of selective outcome reporting? [Short fo
f Was the study apparently free of other problems that could put it at a risk of bias? [nor radiological beneﬁts of the use of HA-coated femoral
stems13,17,18 and others showing improved clinical and radiological
outcomes with the use of HA-coated femoral stems.15,20 As single
RCTs can be limited if theyare underpowered, and some low-quality
RCTs provide biased estimates of treatment efﬁcacy, reviewing the
available RCTs does not provide a deﬁnitive answer as to whether
the clinical and radiological outcomes of THA are improved by the
use of HA-coated femoral stems. Meta-analysis provides a method
to quantitatively analyze the results of multiple, similar RCTs, which
effectively increases the sample size and improves the power of the
analysis. Our meta-analysis found that there were no signiﬁcant
statistical differences in postoperative Harris hip score or radio-
logical results between primary THAs using HA-coated versus non-
HA-coated femoral stems; however, HA-coated femoral stems can
reduce the incidence of postoperative thigh pain.
Of the six studies in our analysis that reported postoperative
Harris hip score, only one15 found a higher Harris hip score in the
HA group than the non-HA group. This result, which contradicts the
result of our meta-analysis, may be due to the small sample sizes
used in the study. Only 14 hips in the HA group and 12 hips in the
non-HA groupwere followed up sufﬁciently, so the outcome data in
this study are very limited. Gandhi et al. performed a meta-analysis
of 9 studies, their results showed no difference in postoperative
Harris hip score between HA-coated and non-HA-coated femoral
stems in primary THA21; however, both RCTs and non-RCTs were
included in their meta-analysis. Since there is a greater risk of se-
lection bias in non-RCTs, pooling these studies with RCTs for meta-
analysis may introduce bias and lead to misleading results. Addi-
tionally, a meta-analysis based on 8 RCTs (857 patients) in 2009 by
Goosen et al.22 demonstrated no difference in postoperative Harrisding?c Incomplete outcome
data addressed?d
Free of selective
reporting?e
Free of other
bias?f
Yes Yes Unclear
lear Yes Yes Unclear
lear Yes Yes Unclear
Yes Yes Unclear
Yes Yes Unclear
Yes Yes Unclear
Yes Yes Unclear
5.0.0: 191e195).
e generation?].
y? [Short form: Blinding?].
come data addressed?].
rm: Free of selective reporting?].
Short form: Free of other bias?].
Table 3
The results of the meta analysis to compare the HA coated versus Non-HA coated femoral stems in primary THA.
Outcome No. of studies No. of follow up Test for heterogeneit
(P value)
Statistical
model
Effect size 95% CI P value
HHS 4 440 <0.00001 R WMD 3.04(4.47e10.54) 0.43
Thigh pain 2 249 0.39 F RR 0.56(0.30e1.02 0.06
Endosteal condensation 4 593 0.17 F RR 1.02(0.93e1.12) 0.64
Radioactive lines 5 643 0.97 F RR 1.01(0.90e1.14) 0.81
Heterotopic ossiﬁcation 3 447 0.20 F RR 0.97(0.77e1.21) 0.77
F ¼ ﬁxed-effect model, R ¼ random-effect model.
Study or Subgroup
Hamadouche 2001
Soballs 1993
Tanzer 2004
Yee 1999
Total (95% CI)
Heterogeneity: Tau² = 49.13; Chi² = 45.14, df = 3 (P < 0.00001); I² = 93%
Test for overall effect: Z = 0.79 (P = 0.43)
Mean
88.52
98
91.9
85
SD
17.53
0.8
10.6
15.4
Total
21
14
159
27
221
Mean
85.54
87
91.3
89
SD
16.2
3.9
11.2
13.4
Total
21
12
159
27
219
Weight
19.2%
29.1%
29.0%
22.7%
100.0%
IV, Random, 95% CI
2.98 [-7.23, 13.19]
11.00 [8.75, 13.25]
0.60 [-1.80, 3.00]
-4.00 [-11.70, 3.70]
3.04 [-4.47, 10.54]
ecnereffiDnaeMecnereffiDnaeMAH-noNAH
IV, Random, 95% CI
-100 -50 0 50 100
Favours HAF avours Non-HA
Fig. 2. Comparison of harris hip score between HA coated and non HA coated femoral stems in primary THA.
S. Li et al. / International Journal of Surgery 11 (2013) 477e482480
ORIGINAL RESEARCHhip score between the two groups, which is consistent with the
ﬁndings in our analysis.
Thigh pain after THAmay be caused by instability of the femoral
stem or tight ﬁlling of the distal medullary cavity by the rigid
femoral stem.13,23 Our results indicate that HA-coated femoral
stems do not reduce the incidence of postoperative thigh pain after
THA. A study by Kim et al.13 found the incidence of postoperative
thigh pain to be 4% in each group until six months after THA, and no
patient in either group had thigh pain one year after THA. This low
incidence of postoperative thigh pain can be attributed to theStudy or Subgroup
Rasquinha 2002
Yoon 2007
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.75, df = 1 (P = 0.39); I² = 0%
Test for overall effect: Z = 1.88 (P = 0.06)
Events
11
3
14
Total
92
37
129
Events
20
3
23
Total
82
38
120
Weight
87.7%
12.3%
100.0%
M-H,
0.4
1.0
0.5
iRAH-noNAH
Fig. 3. Comparison of thigh pain between HA coated a
Study or Subgroup
Rasquinha 2002
Soballs 1993
Tanzer 2004
Yoon 2007
Total (95% CI)
Total events
Heterogeneity: Chi² = 5.07, df = 3 (P = 0.17); I² = 41%
Test for overall effect: Z = 0.47 (P = 0.64)
Events
92
13
46
33
184
Total
92
14
159
37
302
Events
82
12
41
34
169
Total
82
12
159
38
291
Weight
49.8%
7.6%
23.4%
19.2%
100.0%
M-H, F
1.0
0.9
1.1
1.0
1.02
siRAH-noNAH
Fig. 4. Comparison of endosteal condensation between HA codesign of the femoral stem, which allows excellent proximal ﬁxa-
tion of the femoral stem and minimal contact between the tapered
distal part of the femoral stem and the inner cortex of the femur,
and is not related to HA coating.
Our meta-analysis found that there were no signiﬁcant statis-
tical differences in the presence of endosteal condensation and
radioactive lines after primary THA using HA-coated versus non-
HA-coated femoral stems. This suggests that HA-coated femoral
stems do not expedite or improve the quality of endosteal bone
ingrowth into the prosthetic. Early studies did report improved Fixed, 95% CI
9 [0.25, 0.96]
3 [0.22, 4.77]
6 [0.30, 1.02]
oitaRksiRoitaRks
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours HAF avours Non-HA
nd non HA coated femoral stems in primary THA.
ixed, 95% CI
0 [0.98, 1.02]
4 [0.77, 1.14]
2 [0.78, 1.61]
0 [0.85, 1.17]
 [0.93, 1.12]
oitaRksiRoitaRk
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours HAF avours Non-HA
ated and non HA coated femoral stems in primary THA.
Study or Subgroup
Rasquinha 2002
Soballs 1993
Tanzer 2004
Yee 1999
Yoon 2007
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.53, df = 4 (P = 0.97); I² = 0%
Test for overall effect: Z = 0.24 (P = 0.81)
Events
63
4
84
20
29
200
Total
92
14
159
23
37
325
Events
54
4
83
22
31
194
Total
82
12
159
27
38
318
Weight
29.2%
2.2%
42.5%
10.4%
15.7%
100.0%
M-H, Fixed, 95% CI
1.04 [0.84, 1.28]
0.86 [0.27, 2.71]
1.01 [0.82, 1.25]
1.07 [0.84, 1.36]
0.96 [0.77, 1.21]
1.01 [0.90, 1.14]
oitaRksiRoitaRksiRAH-noNAH
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours HAF avours Non-HA
Fig. 5. Comparison of radioactive lines between HA coated and non HA coated femoral stems in primary THA.
Study or Subgroup
Tanzer 2004
Yee 1999
Yoon 2007
Total (95% CI)
Total events
Heterogeneity: Chi² = 3.20, df = 2 (P = 0.20); I² = 38%
Test for overall effect: Z = 0.29 (P = 0.77)
Events
67
14
4
85
Total
159
27
37
223
Events
62
20
6
88
Total
159
27
38
224
Weight
70.5%
22.7%
6.7%
100.0%
M-H, Fixed, 95% CI
1.08 [0.83, 1.41]
0.70 [0.46, 1.07]
0.68 [0.21, 2.23]
0.97 [0.77, 1.21]
oitaR ksiRoitaR ksiRAH-noNAH
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours HAF avours Non-HA
Fig. 6. Comparison of heterotopic ossiﬁcation between HA coated and non HA coated femoral stems in primary THA.
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however, recent studies have not demonstrated any radiological
advantages of HA coating. Camazzola et al.5 showed that all femoral
stems were well ﬁxed with no subsidence and no circumferential
radioactive lines in 43 hips (28 in the HA group, 15 in the non-HA
group) at 13 years follow-up. Additionally, Goosen’s meta-
analysis based on 8 RCTs (857 patients) demonstrated no differ-
ence in the presence of endosteal condensation (RR: 1.04, P ¼ 0.66)
and radioactive lines (RR: 1.02, P ¼ 0.74) between the HA and non-
HA groups.22 A study of cadaveric specimens showed that bone
ingrowth into the prosthesis is related to the patients age after
primary THA using HA-coated femoral stems.25 Younger patients
had better bone ingrowth than older patients. A prospective study
of 38 patients with an average age of 42 years (range from 22 to 49)
by Singh et al.26 noted 100% survival after THA with HA-coated
femoral stems at 12 years follow-up. Unfortunately, their tech-
niques for measuring femoral stem looseness were different from
those of the studies included in our meta-analysis, so we were
unable to pool the results of this study with those of the RCTs that
we included in our analysis.
Our study has some limitations. First, we did not hand search
journals and did not try to identify unpublished studies, Thus we
may have missed some related studies and introduced publication
bias into our analysis. Also, since there are only a few included
studies, we cannot use funnel plots to detect publication bias.
Second, the geometric design of the prosthetic femoral stems was
not the same in all of the studies included in our meta-analysis.
Although all of the studiesconsidered the use of HA-coated versus
non-HA-coated femoral stems in primary THA, their ﬁndings
regarding the clinical effectiveness of the HA coating are not
consistent. Finally, the measurement techniques for some of theoutcome variables differed between studies and in these cases we
were unable to pool the results and perform a combined analysis.
Chambers et al., through a comprehensive review of literature,
found that HA coating can enhance the proximal stability of femoral
stems and the osseointegration of HA-coated tapered femoral stems
after THA.27 However, some of the studies included in their review
suffered from inferior methodology, which may have led to misin-
terpretation. In our study, RCTs and studies of bilateral THAs inwhich
HA-coated femoral stems were used in one hip and not in the other
were included when the allocation of the two techniques to the
operated hips was randomized. All of the studies included in our
meta-analysis had high quality methodological design, improving
the reliability of ourmeta-analysis result. In summary,meta-analysis
of well-designed RCTs demonstrates that the use of HA-coated
femoral stems inprimary THAhas no clinical or radiological beneﬁts.
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